Corvus Pharmaceuticals (CRVS) Accumulated Depreciation & Amortization: 2022-2025
Historic Accumulated Depreciation & Amortization for Corvus Pharmaceuticals (CRVS) over the last 4 years, with Sep 2025 value amounting to $28,000.
- Corvus Pharmaceuticals' Accumulated Depreciation & Amortization rose 40.00% to $28,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $114,000, marking a year-over-year decrease of 19.15%. This contributed to the annual value of $100,000 for FY2024, which is 50.00% down from last year.
- Corvus Pharmaceuticals' Accumulated Depreciation & Amortization amounted to $28,000 in Q3 2025, which was down 3.45% from $29,000 recorded in Q2 2025.
- Over the past 5 years, Corvus Pharmaceuticals' Accumulated Depreciation & Amortization peaked at $4.3 million during Q1 2022, and registered a low of $20,000 during Q3 2024.
- Its 3-year average for Accumulated Depreciation & Amortization is $34,364, with a median of $29,000 in 2025.
- In the last 5 years, Corvus Pharmaceuticals' Accumulated Depreciation & Amortization plummeted by 98.69% in 2023 and then spiked by 40.00% in 2025.
- Corvus Pharmaceuticals' Accumulated Depreciation & Amortization (Quarterly) stood at $127,000 in 2022, then slumped by 39.37% to $77,000 in 2023, then crashed by 54.55% to $35,000 in 2024, then soared by 40.00% to $28,000 in 2025.
- Its last three reported values are $28,000 in Q3 2025, $29,000 for Q2 2025, and $22,000 during Q1 2025.